Ascendis Pharma A (ASND) Change in Taxes (2014 - 2015)

Ascendis Pharma A (ASND) reported Change in Taxes of -$134586.5 for Q3 2015, up 43.67% on a YoY basis from -$93679.4 in Q3 2014, and down 109.97% sequentially from -$64098.2 in Q2 2015.

Ascendis Pharma A (ASND) Change in Taxes (2014 - 2015) Analysis & Trends

Ascendis Pharma A (ASND) has 2 years of Change in Taxes data on file, last reported at -$134586.5 in Q3 2015.

  • For the quarter ending Q3 2015, Change in Taxes rose 43.67% year-over-year to -$134586.5; the trailing twelve-month figure through Sep 2015 stood at -$990248.2 (changed N/A YoY), and the FY2014 full-year result was -$1.1 million, down 234.61% from the prior year.
  • Change in Taxes eased to -$134586.5 in Q3 2015, from -$64098.2 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of -$53444.3 in Q1 2014 to a low of -$724903.4 in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ascendis Pharma A 15.31 Bn 14.64 Bn 268.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 -134,586.47
Sep 30, 2015 -134,586.47
Jun 30, 2015 -64,098.19
Jun 30, 2015 -64,098.19
Mar 31, 2015 -66,660.12
Mar 31, 2015 -66,660.12
Dec 31, 2014 -724,903.42
Dec 31, 2014 -724,903.42
Sep 30, 2014 -238,912.46
Sep 30, 2014 -238,912.46
Mar 31, 2014 -53,444.25
Mar 31, 2014 -53,444.25